Immunovant, Inc. IMVT Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s accrued expenses?
- Immunovant, Inc. (IMVT) reported accrued expenses of $175K in Q1 2026.
- How has Immunovant, Inc.'s accrued expenses changed year-over-year?
- Immunovant, Inc.'s accrued expenses decreased by 35.9% year-over-year, from $273K to $175K.
- What is the long-term trend for Immunovant, Inc.'s accrued expenses?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s accrued expenses has grown at a -59.0% compound annual growth rate (CAGR), from $15.16M to $175K.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.